Cardinal Health (CAH) Tops Q4 EPS by 7c, Offers FY Guidance

Cardinal Health (NYSE: CAH) reported Q4 EPS of $1.00, $0.07 better than the analyst estimate of $0.93. Revenue for the quarter came in at $36.7 billion versus the consensus estimate of $36.88 billion.

GUIDANCE:

Cardinal Health sees FY2021 EPS of $5.25-$5.65, versus the consensus of $5.54.

Interest and other $190M - $215M
Non-GAAP effective tax rate 24.0% - 26.0%
Diluted weighted average shares outstanding 292M - 296M
Capital expenditures $400M - $450M

For earnings history and earnings-related data on Cardinal Health (CAH) click here.

You May Also Be Interested In

• Cardinal Health (CAH) PT Raised to $250 at Mizuho
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c